Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-07-005918
Filing Date
2007-03-16
Accepted
2007-03-16 15:53:20
Documents
12
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 CYTOGEN CORPORATION 10-K 12-31-2006 form10-k.htm 10-K 2760944
2 EXHIBIT 10.75 ex10_75.htm EX-10.75 46091
3 EXHIBIT 10.76 ex10_76.htm EX-10.76 154891
4 EXHIBIT 21 ex21.htm EX-21 7228
5 EXHIBIT 23.1 ex23_1.htm EX-23.1 5320
6 EXHIBIT 23.2 ex23_2.htm EX-23.2 2846
7 EXHIBIT 31.1 ex31_1.htm EX-31.1 10231
8 EXHIBIT 31.2 ex31_2.htm EX-31.2 10384
9 EXHIBIT 32.1 ex32_1.htm EX-32.1 5880
10 EXHIBIT 32.2 ex32_2.htm EX-32.2 5896
11 CYTOGEN CORPORATE LOGO logo.jpg GRAPHIC 3497
12 GRAPH graph.jpg GRAPHIC 36140
  Complete submission text file 0001140361-07-005918.txt   3065994
Mailing Address 650 COLLEGE RD EAST STE 3100 PRINCETON NJ 08540
Business Address 650 COLLEGE RD EAST STE 3100 PRINCETON NJ 08540 6099878200
CYTOGEN CORP (Filer) CIK: 0000725058 (see all company filings)

EIN.: 222322400 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14879 | Film No.: 07700123
SIC: 2834 Pharmaceutical Preparations